Unintended Consequences of the ACA on Specialty Pharmacy

Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.

Related Content:

InterviewsSpecialty Pharmacy

Expert: Cell, Gene Therapy Research Has Weathered the Storm of COVID-19, Leaving a Bright Future Ahead

Expert: Cell, Gene Therapies Provide the Important Opportunity to ‘Move Beyond Chronic Disease Management to Curative Areas’

FDA Grants Breakthrough Therapy Designation to Repotrectinib for ROS1-Positive Metastatic NSCLC